1. >
  2. search-en


Found 382 Results
Page 1 of 39

Annual General Meeting 2021

COMBINED GENERAL MEETING OF JUNE 10, 2021 IN CAMERA   05/05/2021 – Preliminary meeting notice published in the Official Bulletin […]


Publication of the 2020 Annual Financial Report

Paris (France), April 23, 2021 – 7.00 pm CEST – Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: […]



Onxeo Reports Full-Year 2020 Financial Results and Provides Business Update

Several major clinical milestones achieved in 2020 by AsiDNA™, including promising initial results in combination with chemotherapy and the launch […]


Annual Financial Results 2020

The management will comment the financial results and provide an update on the Company’s activities and perspectives through a video […]


Combined Annual Shareholders’ Meeting

More information coming soon 

MEET2WIN – European Oncology Partnering Convention

For more information, visit the MEET2WIN Convention website   To meet with us during the Convention, please contact bd@onxeo.com

Onxeo to Present New Preclinical Data at AACR 2021

Confirming the effect of AsiDNA™ on resistance to KRAS inhibitors Introducing OX400, a new generation of PARP interfering cancer drug […]

Tags: ,


B-Smart – Interview of Judith Greciet, CEO of Onxeo

Watch the interview (in French)


Onxeo will publish its annual results on April 21, 2021

The Annual General Meeting will be held on June 10, 2021 Paris (France), March 24, 2021 – 6 pm CET […]



Page 1 of 39

No more results